ACTIVE

PHARMAPRODUCTS

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

69,2 k €

-47.5% YoY

Gross margin

178 k €

-17.7% YoY

Equity

193,8 k €

+55.6% YoY

Workforce

1,5 ETP

-16.7% YoY

What does PHARMAPRODUCTS do?

PHARMAPRODUCTS is a Public limited company incorporated in 1983. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Heusden-Zolder. It employs on average 1,5 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0424.935.422

Incorporation

17/11/1983

Legal form

Public limited company

Registered office

Pastoor Paquaylaan 81
3550 Heusden-Zolder · FlandreSee on map

Contributed capital

62 000,00 €

Latest accounts

31/12/2025

Average workforce

1,5 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	178 k €	-17.7%	216,3 k €	-4.8%	227,2 k €	-2.9%	234,1 k €	+26.8%	184,6 k €	+3.0%	179,2 k €	+1.2%	177 k €	+6.6%	166 k €	+17.9%	140,8 k €	-15.5%	166,7 k €	-1.1%	168,6 k €	-1.0%	170,3 k €	+7.3%	158,7 k €	-1.3%	160,8 k €	+14.2%	140,8 k €	-7.4%	152,1 k €	-4.1%	158,7 k €	-12.3%	181,1 k €	+20.8%	149,9 k €	+17.3%	127,7 k €
EBITDA	111,9 k €	-23.4%	146,1 k €	+1.8%	143,5 k €	-12.8%	164,6 k €	+22.8%	134 k €	+2.5%	130,8 k €	+2.3%	127,8 k €	+11.0%	115,1 k €	+18.9%	96,9 k €	-24.0%	127,5 k €	-0.7%	128,4 k €	-2.0%	131 k €	+10.6%	118,4 k €	+1.2%	116,9 k €	+19.5%	97,8 k €	-13.1%	112,6 k €	-9.1%	123,8 k €	-14.7%	145,2 k €	+27.7%	113,7 k €	+25.6%	90,5 k €
Operating result	98 k €	-26.9%	133,9 k €	+0.3%	133,5 k €	-13.6%	154,6 k €	+24.5%	124,1 k €	+2.2%	121,4 k €	+21.0%	100,3 k €	+15.2%	87,1 k €	+25.3%	69,5 k €	-30.6%	100,1 k €	+0.5%	99,7 k €	-3.8%	103,6 k €	+16.3%	89,1 k €	+1.6%	87,6 k €	+58.9%	55,1 k €	-21.8%	70,5 k €	-15.9%	83,9 k €	-20.5%	105,5 k €	+39.9%	75,4 k €	+41.7%	53,2 k €
Net result	69,2 k €	-47.5%	131,8 k €	-24.3%	174,1 k €	-9.9%	193,1 k €	+20.7%	160 k €	+5.6%	151,4 k €	+25.5%	120,7 k €	+11.8%	107,9 k €	+21.7%	88,7 k €	-23.4%	115,8 k €	-5.3%	122,4 k €	+17.9%	103,8 k €	+3.4%	100,4 k €	+12.1%	89,5 k €	+55.3%	57,7 k €	-18.1%	70,4 k €	-13.6%	81,5 k €	-23.0%	105,7 k €	+34.9%	78,4 k €	+39.7%	56,1 k €
Balance sheet
Equity	193,8 k €	+55.6%	124,6 k €	+0.2%	124,3 k €	+0.1%	124,2 k €	+0.1%	124,1 k €	+0.4%	123,6 k €	+1.2%	122,2 k €	+0.1%	122 k €	+1.2%	120,6 k €	+0.6%	119,9 k €	+0.7%	119,1 k €	+0.7%	118,2 k €	+0.7%	117,4 k €	+0.8%	116,5 k €	+0.5%	116 k €	+0.1%	115,8 k €	+8.5%	106,7 k €	+10.3%	96,8 k €	+6.3%	91 k €	+5.7%	86,1 k €
Total assets	501 k €	+56.0%	321,2 k €	-39.7%	532,9 k €	+12.5%	473,6 k €	+8.0%	438,7 k €	-4.1%	457,5 k €	-5.8%	485,6 k €	+4.8%	463,4 k €	+5.0%	441,3 k €	-5.8%	468,4 k €	-7.1%	504,1 k €	+5.8%	476,5 k €	-22.6%	615,4 k €	-4.8%	646,2 k €	+4.1%	620,7 k €	-1.5%	630,2 k €	-3.6%	653,8 k €	-4.3%	683,2 k €	+5.9%	644,9 k €	+6.2%	607,1 k €
Cash	139,5 k €	+418%	26,9 k €	-88.1%	227,1 k €	+17.1%	193,9 k €	+14.7%	169,1 k €	-11.9%	192 k €	-18.7%	236,1 k €	+63.6%	144,3 k €	+101%	71,7 k €	-47.9%	137,4 k €	-32.3%	203 k €	+58.0%	128,5 k €	-12.7%	147,2 k €	-39.5%	243,3 k €	+18.0%	206,2 k €	+1.0%	204,1 k €	+19.8%	170,4 k €	+13.4%	150,3 k €	+21.0%	124,2 k €	+29.4%	96 k €
Debts	307,2 k €	+56.3%	196,6 k €	-51.9%	408,6 k €	+17.4%	348 k €	+11.2%	313 k €	-6.2%	333,8 k €	-7.6%	361,1 k €	+6.4%	339,3 k €	+6.0%	320,1 k €	-8.0%	348 k €	-9.5%	384,4 k €	+7.5%	357,7 k €	-28.0%	496,9 k €	-5.4%	525,5 k €	+4.3%	503,9 k €	-1.9%	513,6 k €	-5.9%	546,1 k €	-6.7%	585,5 k €	+5.9%	552,8 k €	+6.3%	519,8 k €
Other
Workforce	1,5 ETP	-16.7%	1,8 ETP	+5.9%	1,7 ETP	0.0%	1,7 ETP	+54.5%	1,1 ETP	-26.7%	1,5 ETP	+7.1%	1,4 ETP	+7.7%	1,3 ETP	+18.2%	1,1 ETP	-15.4%	1,3 ETP	+30.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 11 ended

Active mandates

Bo'n Management

Director · 1008.911.549

Represented by Thomas Boonen

Active

Ended mandates

Bo'n Management

Managing director · since 31 décembre 2024 · 1008.911.549

Represented by Thomas BOONEN

Ended

LORE VAN DER GAAST

Director · since 01 juin 2017 · until 01 juin 2023

Ended

PHARMAPRODUCTS

Managing director · since 01 juin 2017 · until 01 juin 2023 · 0424.935.422

Ended

MARIA VERBEEK

Director · since 16 avril 2013 · until 16 avril 2019

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	18/06/2026	13/06/2025	24/06/2024	30/08/2023	07/09/2022	31/08/2021
General meeting	28/04/2026	02/06/2025	01/06/2024	01/06/2023	01/06/2022	01/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	28/04/2026	18/06/2026	Dutch	PDF
Abridged model	31/12/2024	02/06/2025	13/06/2025	Dutch	PDF
Abridged model	31/12/2023	01/06/2024	24/06/2024	Dutch	PDF
Abridged model	31/12/2022	01/06/2023	30/08/2023	Dutch	PDF
Abridged model	31/12/2021	01/06/2022	07/09/2022	Dutch	PDF
Abridged model	31/12/2020	01/06/2021	31/08/2021	Dutch	PDF
Abridged model	31/12/2019	02/06/2020	30/06/2020	Dutch	PDF
Abridged model	31/12/2018	03/06/2019	03/07/2019	Dutch	PDF
Abridged model	31/12/2017	01/06/2018	29/06/2018	Dutch	PDF
Abridged model	31/12/2016	01/06/2017	29/06/2017	Dutch	PDF
Abridged model	31/12/2015	01/06/2016	28/06/2016	Dutch	PDF
Abridged model	31/12/2014	01/06/2015	30/06/2015	Dutch	PDF
Abridged model	31/12/2013	02/06/2014	01/07/2014	Dutch	PDF
Abridged model	31/12/2012	03/06/2013	01/07/2013	Dutch	PDF
Abridged model	31/12/2011	01/06/2012	29/06/2012	Dutch	PDF
Abridged model	31/12/2010	01/06/2011	29/06/2011	Dutch	PDF
Abridged model	31/12/2009	01/06/2010	30/06/2010	Dutch	PDF
Abridged model	31/12/2008	30/06/2009	22/07/2009	Dutch	PDF
Abridged model	31/12/2007	02/06/2008	01/07/2008	Dutch	PDF
Abridged model	31/12/2006	01/06/2007	21/06/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 11 ended

Active mandates

Bo'n Management

Director · 1008.911.549

Represented by Thomas Boonen

Active

Ended mandates

Bo'n Management

Managing director · since 31 décembre 2024 · 1008.911.549

Represented by Thomas BOONEN

Ended

LORE VAN DER GAAST

Director · since 01 juin 2017 · until 01 juin 2023

Ended

PHARMAPRODUCTS

Managing director · since 01 juin 2017 · until 01 juin 2023 · 0424.935.422

Ended

MARIA VERBEEK

Director · since 16 avril 2013 · until 16 avril 2019

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates12/02/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/10/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates21/08/2017
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares30/05/2014
BENAMING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates30/04/2013
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/09/2011
ONTSLAGEN - BENOEMINGEN
PDF
Mandates28/07/2006
ONTSLAGEN - BENOEMINGEN
PDF
Mandates29/10/2004
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202569,2 k €↓
2024
Annual accounts 2024131,8 k €↓
2023
Annual accounts 2023174,1 k €↓
2022
Annual accounts 2022193,1 k €↑
2021
Annual accounts 2021160 k €↑
2020
Annual accounts 2020151,4 k €↑
2019
Annual accounts 2019120,7 k €↑
2018
Annual accounts 2018107,9 k €↑
2017
Annual accounts 201788,7 k €↓
2016
Annual accounts 2016115,8 k €↓
2015
Annual accounts 2015122,4 k €↑
2014
Annual accounts 2014103,8 k €↑
2013
Annual accounts 2013100,4 k €↑
2013
Name changePharmaproducts NV
2012
Annual accounts 201289,5 k €↑
2011
Annual accounts 201157,7 k €↓
2010
Annual accounts 201070,4 k €↓
2009
Annual accounts 200981,5 k €↓
2008
Annual accounts 2008105,7 k €↑
2007
Annual accounts 200778,4 k €↑
2006
Annual accounts 200656,1 k €
2006
Name changeApotheek Berkenbos
17/11/1983
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMAPRODUCTS

Overview

What does PHARMAPRODUCTS do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline